Sarcoidosis is a systemic, immune-mediated illness, and major subtype of the interstitial
lung diseases (ILD). 1 In the more than 150 years since it was first described 2 sarcoidosis …

Sarcoidosis is a systemic granulomatous disease of unknown cause that predominantly
affects young and middle-aged adults. Intrathoracic involvement including lymphatic nodes …

Sarcoidosis is a systemic inflammatory disorder of unknown origin. Its clinical course ranges
from asymptomatic disease with spontaneous remission to chronic illness resulting in …

Sarcoidosis is a chronic systemic disorder characterised by granulomatous inflammation
targeted to an as-yet-unidentified antigen [1]. First described over 100 years ago by Caesar …

Sarcoidosis epidemiology: recent estimates of incidence, pre... : Current Opinion in Pulmonary
Medicine Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors …

Methods: A prospective observational study was carried out at the University of Alberta
Hospital. Patients with confirmed sarcoidosis (stages 0-4) were recruited from subspecialty …

The prevalence of sarcoidosis in the United States is unknown, with estimates ranging
widely from 1 to 40 per 100,000. We sought to determine the prevalence of sarcoidosis in …

The clinical expression, natural history, and prognosis of sarcoidosis are highly variable and
its course is often unpredictable. 1 Clinical manifestations vary with the organs involved. 1, 2 …

It is well-recognized that sarcoidosis is a multisystemic disorder of unknown etiology that can
present with a myriad of signs and symptoms, but most commonly presents with pulmonary …

Sarcoidosis is a systemic granulomatous disorder that affects individuals of all racial/ethnic
origins and occurs at any time of life. Spontaneous remission is frequent and may occur in 2 …